Benjamin J Morasco1,2, Melissa H Adams3,4, Elizabeth R Hooker3, Patricia E Maloy3, Erin E Krebs5,6, Travis I Lovejoy3,4,7, Somnath Saha3,8,9, Steven K Dobscha3,4. 1. Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, USA. benjamin.morasco@va.gov. 2. Department of Psychiatry, Oregon Health & Science University, Portland, USA. benjamin.morasco@va.gov. 3. Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, USA. 4. Department of Psychiatry, Oregon Health & Science University, Portland, USA. 5. Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, Minneapolis, USA. 6. Department of Medicine, Division of General Internal Medicine, University of Minnesota Medical School, Minneapolis, USA. 7. School of Public Health, Oregon Health & Science University and Portland State University, Portland, USA. 8. Primary Care Division, VA Portland Health Care System, Portland, USA. 9. Division of General Internal Medicine, Department of Medicine, Oregon Health & Science University, Portland, USA.
Abstract
BACKGROUND: Interventions to reduce harms related to prescription opioids are needed in primary care settings. OBJECTIVE: To determine whether a multicomponent intervention, Improving the safety of opioid therapy (ISOT), is efficacious in reducing prescription opioid harms. DESIGN: Clinician-level, cluster randomized clinical trial. ( ClinicalTrials.gov : NCT02791399) SETTING: Eight primary care clinics at 1 Veterans Affairs health care system. PARTICIPANTS: Thirty-five primary care clinicians and 286 patients who were prescribed long-term opioid therapy (LTOT). INTERVENTION: All clinicians participated in a 2-hour educational session on patient-centered care surrounding opioid adherence monitoring and were randomly assigned to education only or ISOT. ISOT is a multicomponent intervention that included a one-time consultation by an external clinician to the patient with monitoring and feedback to clinicians over 12 months. MAIN MEASURES: The primary outcomes were changes in risk for prescription opioid misuse (Current Opioid Misuse Measure) and urine drug test results. Secondary outcomes were quality of the clinician-patient relationship, other prescription opioid safety outcomes, changes in clinicians' opioid prescribing characteristics, and a non-inferiority analysis of changes in pain intensity and functioning. KEY RESULTS: ISOT did not decrease risk for prescription opioid misuse (difference between groups = -1.12, p = 0.097), likelihood of an aberrant urine drug test result (difference between groups = -0.04, p=0.401), or measures of the clinician-patient relationship. Participants allocated to ISOT were more likely to discontinue prescription opioids (20.0% versus 8.1%, p = 0.007). ISOT did not worsen participant-reported scores of pain intensity or function. CONCLUSIONS: ISOT did not impact risk for prescription opioid misuse but did lead to increased likelihood of prescription opioid discontinuation. More intensive interventions may be needed to impact treatment outcomes.
BACKGROUND: Interventions to reduce harms related to prescription opioids are needed in primary care settings. OBJECTIVE: To determine whether a multicomponent intervention, Improving the safety of opioid therapy (ISOT), is efficacious in reducing prescription opioid harms. DESIGN: Clinician-level, cluster randomized clinical trial. ( ClinicalTrials.gov : NCT02791399) SETTING: Eight primary care clinics at 1 Veterans Affairs health care system. PARTICIPANTS: Thirty-five primary care clinicians and 286 patients who were prescribed long-term opioid therapy (LTOT). INTERVENTION: All clinicians participated in a 2-hour educational session on patient-centered care surrounding opioid adherence monitoring and were randomly assigned to education only or ISOT. ISOT is a multicomponent intervention that included a one-time consultation by an external clinician to the patient with monitoring and feedback to clinicians over 12 months. MAIN MEASURES: The primary outcomes were changes in risk for prescription opioid misuse (Current Opioid Misuse Measure) and urine drug test results. Secondary outcomes were quality of the clinician-patient relationship, other prescription opioid safety outcomes, changes in clinicians' opioid prescribing characteristics, and a non-inferiority analysis of changes in pain intensity and functioning. KEY RESULTS: ISOT did not decrease risk for prescription opioid misuse (difference between groups = -1.12, p = 0.097), likelihood of an aberrant urine drug test result (difference between groups = -0.04, p=0.401), or measures of the clinician-patient relationship. Participants allocated to ISOT were more likely to discontinue prescription opioids (20.0% versus 8.1%, p = 0.007). ISOT did not worsen participant-reported scores of pain intensity or function. CONCLUSIONS: ISOT did not impact risk for prescription opioid misuse but did lead to increased likelihood of prescription opioid discontinuation. More intensive interventions may be needed to impact treatment outcomes.
Authors: Roger Chou; Judith A Turner; Emily B Devine; Ryan N Hansen; Sean D Sullivan; Ian Blazina; Tracy Dana; Christina Bougatsos; Richard A Deyo Journal: Ann Intern Med Date: 2015-02-17 Impact factor: 25.391
Authors: Joanna L Starrels; William C Becker; Mark G Weiner; Xuan Li; Moonseong Heo; Barbara J Turner Journal: J Gen Intern Med Date: 2011-02-24 Impact factor: 5.128
Authors: Erin E Krebs; Amy Gravely; Sean Nugent; Agnes C Jensen; Beth DeRonne; Elizabeth S Goldsmith; Kurt Kroenke; Matthew J Bair; Siamak Noorbaloochi Journal: JAMA Date: 2018-03-06 Impact factor: 56.272
Authors: Kathleen W Saunders; Kate M Dunn; Joseph O Merrill; Mark Sullivan; Constance Weisner; Jennifer Brennan Braden; Bruce M Psaty; Michael Von Korff Journal: J Gen Intern Med Date: 2010-01-05 Impact factor: 5.128
Authors: Juha Puustinen; Janne Nurminen; Minna Löppönen; Tero Vahlberg; Raimo Isoaho; Ismo Räihä; Sirkka-Liisa Kivelä Journal: BMC Geriatr Date: 2011-11-01 Impact factor: 3.921